The scientific community has determined that exposure to asbestos dramatically increases the risk that cigarette smokers will be diagnosed with malignant mesothelioma, and the same is true of lung cancer. Yet despite incontrovertible evidence in support of this connection, Consolidated Rail Corporation (Conrail) argued in court against its responsibility for a longtime railroad worker’s diagnosis
When people are first diagnosed with malignant mesothelioma or other asbestos-related diseases, they’re often shocked to learn that they were exposed to asbestos by iconic companies like Ford Motor Company. That is exactly what happened to John Decastro, who was diagnosed with lung cancer after years of having maintained his Ford vehicles, whose parts were
One of the first things that a mesothelioma victim is told after their diagnosis is that the disease has a very short life expectancy. Some are told to get their affairs in order, while others may have a prognosis that promises a year, perhaps two. The medical community has been striving to find better treatment
Keytruda (pembrolizumab) is an immunotherapy drug for cancer treatment originally approved for patients with specific genetic markers. Continuing studies led to Keytruda being approved for advanced pleural mesothelioma and some types of asbestos lung cancer. Facts About Keytruda Is Pembrolizumab Approved for Mesothelioma? Unlike other cancer drugs, Keytruda’s FDA approval is based not only on
Lung cancer is the second most common type of cancer and the leading cause of cancer death in the U.S., and some cases are triggered by asbestos exposure. The prognosis for asbestos lung cancer is poor. Early diagnosis and treatment can increase life expectancy. What Is Asbestos Lung Cancer? Asbestos-related lung cancer is a cancer
Mesothelioma is not a type of lung cancer. They are two different types of cancer that are diagnosed and treated very differently, but because mesothelioma is rare, it is often misdiagnosed as lung cancer. Getting a thorough diagnosis for symptoms, including second or third opinions, is essential. Mesothelioma vs. Lung Cancer Mesothelioma and lung cancer
A report published by the European Union’s statistical office demonstrates that mesothelioma accounted for 16,469 of the 40,538 occupational cancer cases officially recognized in the European Union between 2013 and 2023. The report issued by Eurostat shows that despite steps taken to minimize asbestos exposure, the rare disease represents 40.6 percent of all diagnosed work-related
Malignant pleural mesothelioma is a notoriously difficult form of cancer to treat. The aggressive, asbestos-related disease is always considered fatal, with most patients succumbing to their illness within a year of diagnosis. However, the Froedtert & the Medical College of Wisconsin health network recently reported good results after treating a patient with immunotherapy drugs.
Mesothelioma is one of the most challenging forms of cancer to treat. The aggressive disease has proven resistant to traditional protocols and is always considered fatal. This week a study reveals a new way to combat therapy-resistant cancers, and mesothelioma researchers are hoping that it can be applied to the rare and deadly asbestos-related malignancy.
The Peter MacCallum Cancer Center is a renowned cancer treatment center that has been a leader in mesothelioma research. Located in Melbourne, Australia, the facility affectionately referred to as “Peter Mac” is credited with several breakthroughs in cancer treatment, including having discovered the “Hippo” signaling pathway that holds promise for a better understanding of the